H. H. Lervang

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

Antoinette Moran, Brian N. Bundy, Dorothy Becker et al. · The Lancet · 2013 · 354 citations · Full text

Medicine, Endocrinology, Immunology +14

The effects of dietary supplementation with n‐3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial

Gunnar Lauge Nielsen, K L Faarvang, B. Thomsen et al. · European Journal of Clinical Investigation · 1992 · 150 citations

Agriculture, Nutrition, Nutritional Sciences +16

Decreased Interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids

G. T. Espersen, N. nGrunnet, H. H. Lervang et al. · Clinical Rheumatology · 1992 · 120 citations

Life Sciences, Immunology, Nutritional Sciences +17

Liraglutide treatment reduced interleukin‐6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy

Christina Brock, Christian Stevns Hansen, Jesper Karmisholt et al. · British Journal of Clinical Pharmacology · 2019 · 88 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Long-term supplementation with n-3 fatty acids, II: effect on neutrophil and monocyte chemotaxis

Erik Berg Schmidt, Kim Varming, Jens Oluf Pedersen et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 1992 · 80 citations

Life Sciences, Nutrition, Nutritional Sciences +16